secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2026-09-16T20:06:04+00:00
Accession:  0001213900-26-100515
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea warrants expire Sept 17, 2026; will cease trading and be delisted
--------------------------------------------------------------------------

- Warrants (KTTAW) expire on September 17, 2026; unexercised warrants become worthless.
- Warrants will stop trading on Nasdaq; Form 25 will be filed to delist and deregister them.
- Common stock (KTTA) continues to trade on Nasdaq; no change to common listing.
- Expiration per terms of Warrant Agency Agreement with VStock Transfer, LLC; no extension noted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390026100515/0001213900-26-100515-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390026100515/ea0305372-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-100515

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer